Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma

Published:2017-10 Issue:4-5 Volume:3 Page:421-427
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Manley Brandon John,Zabor Emily C.,Casuscelli Jozefina,Tennenbaum Daniel M.,Redzematovic Almedina,Becerra Maria F.,Benfante Nicole,Sato Yusuke,Morikawa Teppei,Kume Haruki,Fukayama Masashi,Homma Yukio,Ogawa Seishi,Arcila Maria E.,Voss Martin H.,Feldman Darren R.,Coleman Jonathan A.,Reuter Victor E.,Motzer Robert J.,Russo Paul,Hsieh James J.,Hakimi A. Ari

Publisher

Elsevier BV

Subject

Urology

Reference25 articles.

1. The global burden of cancer 2013;JAMA Oncol,2015

2. Comprehensive molecular characterization of clear cell renal cell carcinoma;Nature,2013

3. Variation in genomic landscape of clear cell renal cell carcinoma across Europe;Scelo;Nat Commun,2014

4. Integrated molecular analysis of clear-cell renal cell carcinoma;Sato;Nat Genet,2013

5. Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma;Guo;Nat Genet,2012

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma;Nature Communications;2024-07-15

2. Sex-specific survival gene mutations are discovered as clinical predictors of clear cell renal cell carcinoma;Scientific Reports;2024-07-09

3. A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2 -Altered Advanced Solid Tumor Malignancies (NCI 10170);Cancer Research Communications;2024-07-01

4. The evolving management of small renal masses;Nature Reviews Urology;2024-02-16

5. Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma;2023-12-06